Multicellular Ovarian Cancer Model for Evaluation of Nanovector Delivery in Ascites and Metastatic Environments

A novel multicellular model composed of epithelial ovarian cancer and fibroblast cells was developed as an in vitro platform to evaluate nanovector delivery and ultimately aid the development of targeted therapies. We hypothesized that the inclusion of peptide-based scaffold (PuraMatrix) in the sphe...

Descripción completa

Detalles Bibliográficos
Autores principales: Winter, Stephen J., Miller, Hunter A., Steinbach-Rankins, Jill M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625169/
https://www.ncbi.nlm.nih.gov/pubmed/34834307
http://dx.doi.org/10.3390/pharmaceutics13111891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625169/
https://www.ncbi.nlm.nih.gov/pubmed/34834307
http://dx.doi.org/10.3390/pharmaceutics13111891

Ejemplares similares